Blindness Awareness Month on Legally Blind No Limits is presented by Prevent Blindness

Blindness Awareness Month on Legally Blind No Limits is presented by Prevent Blindness, the Living Well with Low Vision Initiative and the ASPECT Program! Looking for something fun to tune into during Blindness Awareness Month? Cory Rainford, advocate and creator behind Legally Blind No Limits, is bringing the community together every Tuesday for livestreams filled [Read More]

New Study Finds Higher Prevalence of Age-Related Macular Degeneration (AMD) Cases than Previously Determined and a High Degree of County Variation

A new study “The Prevalence of Age-Related Macular Degeneration in the United States In 2019” published in JAMA Ophthalmology, found that in 2019, there were an estimated 19.83 million Americans were living with some form of age-related macular degeneration (AMD) in 2019. This is an increase of approximately more than 2.75 times previous estimates (which used a more [Read More]

Susvimo implant for Wet AMD Voluntarily Recalled

Susvimo, previously called Port Delivery System with ranibizumab (Lucentis), was FDA-approved on October 21, 2021, for intravitreal use via ocular implant for the treatment of people with wet (neovascular) age-related macular degeneration (AMD). Now, one year later, Genentech has announced that it is voluntarily recalling the implant and the insertion tool in the U.S. As [Read More]